LAmbre Left Atrium Appendage Closure System

Advanced Repositionable LAA Closure Platform Designed for Complex Anatomies

Lifetech Scientific developed the LAmbre as an advanced transcatheter system for left atrial appendage (LAA) closure in patients with non-valvular atrial fibrillation. Designed to reduce thromboembolic risk through minimally invasive intervention, the LAmbre platform stands out through its ability to accommodate highly variable LAA anatomies, fully repositionable implantation design, and low-profile delivery system.

One of the most important advantages of the LAmbre system is its capability to adapt to a wide variety of left atrial appendage anatomies. LAA morphology can vary significantly between patients, creating major technical challenges during closure procedures. Achieving stable implantation in chicken wing, windsock, cauliflower, and cactus-type appendage anatomies is critically important for successful LAA intervention.

The LAmbre system utilizes a unique dual-component structure consisting of an umbrella and cover design that provides broad anatomical adaptability. This configuration allows stable implantation even in anatomies with short landing zones, contributing to the system’s effectiveness in complex LAA cases.

Its flexible structure is particularly advantageous in wide-ostium and multilobed appendage anatomies. Multiple device size options and reduced depth requirements enable treatment of anatomies that may be difficult to manage with conventional closure systems.

Another major strength of the LAmbre platform is its fully repositionable and retrievable deployment capability. Even after full deployment, operators can reposition or completely retrieve the device if necessary. This feature significantly improves procedural precision and implantation safety, especially in anatomically challenging cases.

The repositionable structure helps optimize final device placement to achieve effective sealing and stable fixation. This may contribute to reducing the risk of peri-device leaks during long-term follow-up.

The LAmbre system also features a low-profile delivery sheath architecture. Smaller delivery diameters help minimize vascular and septal trauma during transseptal access procedures, supporting procedural safety in fragile patient populations.

Its nitinol mesh construction provides excellent flexibility and shape-memory performance, while integrated polyester membranes support effective occlusion and rapid endothelialization. The soft anchoring system is designed to improve conformity with the atrial wall and support long-term implant stability.

As a minimally invasive structural heart therapy, the LAmbre system represents an important alternative to surgical treatment approaches. It is particularly valuable for atrial fibrillation patients in whom long-term oral anticoagulation therapy is contraindicated or associated with elevated bleeding risk.

In clinical practice, the LAmbre platform is recognized for its adaptability to complex anatomies, controlled deployment mechanism, and fully repositionable implantation capabilities. The system is increasingly considered an innovative solution for improving procedural success in difficult LAA anatomies.

Compared with competing systems, the LAmbre platform stands out through its broad anatomical compatibility, reduced landing-zone requirements, and fully retrievable deployment structure. These characteristics contribute to its growing adoption in modern structural heart intervention procedures.

In summary, the LAmbre is an advanced LAA closure system designed for complex left atrial appendage anatomies. Through its high anatomical adaptability, repositionable architecture, and controlled implantation approach, the LAmbre platform provides safe and effective transcatheter therapy for structural heart disease management.